Evidence reviewed: 8 November 2026. Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes cold-like symptoms but can lead to bronchiolitis or pneumonia, especially in young infants. Babies may initially have a runny nose and poor feeding, then develop increased breathing effort over the next few days. Some very young infants have no fever; pauses in breathing, poor feeding or reduced activity may be the earliest signs. Prompt recognition and supportive care matter, and preventive options now include maternal RSV vaccination and long-acting antibodies given to infants [1–3].
What is RSV, and how does it affect the lungs?
RSV is an enveloped RNA virus in the Pneumoviridae family. It spreads mainly through respiratory droplets, close contact and contaminated hands or surfaces. The virus infects respiratory epithelial cells. In the lower airways, inflammation, mucus and shed epithelial cells can narrow the small bronchioles, producing wheezing, crackles, fast breathing and difficulty feeding. This syndrome is called bronchiolitis [1,4].
Children commonly acquire RSV early in life, and reinfections can occur. Severity depends on age, prematurity, cardiopulmonary disease, immune status and other factors. Most infections resolve without hospital treatment, but young infants can deteriorate and need close monitoring. In temperate regions RSV commonly peaks in colder months, while timing varies in tropical and subtropical countries; prevention schedules must follow local surveillance and health-authority recommendations [2,3].
Early RSV symptoms in babies
- Runny nose, congestion, sneezing or a new cough.
- Feeding less than usual, tiring during feeds or vomiting after coughing.
- Irritability or reduced activity.
- Fever in some children, but absence of fever does not rule out RSV.
- Wheezing, faster breathing or visible chest-wall retractions as lower respiratory illness develops.
The CDC notes that young infants under six months may have apnea—pauses in breathing—or feeding and activity changes rather than a classic cough-and-fever illness [2]. Symptoms can worsen several days after onset. Parents should pay particular attention to a baby’s breathing and ability to feed rather than judging illness solely by temperature.
Emergency warning signs: when to seek urgent care
Seek emergency medical help immediately if an infant has blue or gray lips, repeated or prolonged pauses in breathing, severe chest retractions, grunting with each breath, marked difficulty breathing, reduced responsiveness or inability to remain awake. Apnea in a young infant is an emergency even if no fever is present [2].
Seek prompt clinical assessment for worsening breathing, rapid breathing with poor feeding, markedly fewer wet diapers, dehydration, persistent fever in an older infant, or any fever in a baby younger than three months. Babies born prematurely or with significant heart, lung or immune-system problems merit a lower threshold for assessment. Do not try to determine the need for oxygen using a consumer pulse oximeter alone [1,2].
What do clinicians look for?
Clinicians assess breathing rate and effort, oxygenation when indicated, hydration, feeding tolerance, alertness and risk factors. RSV bronchiolitis is usually a clinical diagnosis; routine chest X-rays, laboratory panels and viral PCR are not needed for every straightforward case. Targeted testing may be useful in severe illness, infection-control decisions or when the findings suggest a different condition, such as bacterial pneumonia [4].
Hospital admission may be needed if a baby requires supplemental oxygen, cannot maintain hydration, has significant apnea, or needs respiratory support. Oxygen treatment is individualized; there is no safe single oxygen-saturation number that parents can use at home to decide whether a baby is well [4].
Home care for mild RSV illness
Help the baby breathe comfortably
Saline nasal drops and gentle, superficial suction before feeding may help when congestion blocks the nose. Avoid excessive or deep suctioning that could irritate tissues. Keep the baby away from tobacco smoke and allow rest. Continue usual breast milk or formula, offering smaller, more frequent feeds if helpful. Watch urine output and feeding effort [2,4].
Follow safe-sleep guidance: babies should sleep on their backs on a flat, firm sleep surface, not propped upright with pillows or asleep in car seats to improve congestion. For fever or discomfort, ask a healthcare professional which age-appropriate medicine is suitable; avoid aspirin, and do not give ibuprofen to infants younger than six months unless specifically directed by a clinician.
Monitor for worsening illness
A baby who feeds reasonably well, breathes comfortably and remains alert can often recover at home with advice from a healthcare professional. However, changes in breathing or drinking justify reassessment, even if a test previously confirmed RSV. Contact a clinician for worsening symptoms, especially during the first several days [2].
Which treatments actually work for bronchiolitis?
Most care is supportive: appropriate hydration, airway comfort, observation, and hospital oxygen or respiratory support when needed. The American Academy of Pediatrics (AAP) recommends against routine albuterol/salbutamol, epinephrine nebulization, systemic corticosteroids, antibiotics and chest physiotherapy for typical bronchiolitis [4].
RSV is a virus, so an antibiotic does not treat uncomplicated RSV infection; antibiotics are considered only if there is a separate bacterial infection. Inhaled or systemic ribavirin is not routine therapy for otherwise healthy infants with RSV. In unusual cases involving severe immunocompromise, antiviral decisions may require specialist consultation, but this is not standard community management [3,4].
Some children have asthma or another diagnosis in addition to RSV. Those separate conditions may require individualized treatment, which is different from giving bronchodilators or steroids automatically to every infant with bronchiolitis.
Preventing severe RSV: what changed?
Preventive options have improved substantially. In the United States, the CDC recommends protecting most infants using one of two routes: an RSV vaccine given to the pregnant parent or an RSV monoclonal antibody given directly to the infant. Most infants do not need both. Antibodies are not vaccines: they provide ready-made, temporary protection rather than stimulating the baby’s immune system to make its own antibodies [3].
Maternal RSV vaccination
CDC recommends Pfizer’s Abrysvo for eligible pregnant patients at 32–36 weeks’ gestation during the recommended US seasonal vaccination period. Maternal antibodies cross the placenta and help protect the infant during early life. Timing and eligibility matter: a vaccine given too close to delivery may not provide adequate protection for the newborn. Local schedules may differ, particularly outside the United States [3].
Long-acting infant antibodies: nirsevimab and clesrovimab
CDC guidance includes nirsevimab and clesrovimab as long-acting monoclonal antibodies for infants. For infants younger than eight months entering their first RSV season, an infant antibody is generally recommended if the mother did not receive maternal RSV vaccination, the vaccination status is unknown, or the infant was born within 14 days of vaccination [3]. The specific product, dose, timing and eligibility are determined by the clinical team.
Nirsevimab is also recommended for selected children 8–19 months at increased risk of severe RSV entering a second season. Clesrovimab is not interchangeable for this second-season high-risk indication under the referenced CDC guidance [3]. These preventive antibodies reduce the risk of severe RSV disease but do not eliminate infection or replace ordinary respiratory infection prevention.
Who is at greater risk of serious RSV?
- Infants in the first months of life, especially younger than six months.
- Babies born prematurely.
- Children with significant chronic lung disease of prematurity or certain congenital heart conditions.
- Those with major immune-system impairment or selected neuromuscular conditions affecting airway clearance.
- Babies with difficulty feeding or limited access to timely medical care during respiratory illness.
Risk varies. A healthy full-term infant can still develop significant bronchiolitis, so the absence of recognized risk factors should not override concerning clinical signs [1–3].
Practical infection prevention
Wash hands before handling babies, clean frequently touched surfaces, reduce contact with sick visitors, and avoid exposing infants to tobacco smoke. People with respiratory symptoms should postpone close contact with newborns. Breastfeeding when possible supports infant health, although it does not guarantee protection against RSV. Vaccination of household members against other recommended respiratory pathogens may also reduce some respiratory illness risks.
Frequently asked questions
Can RSV be serious without a fever?
Yes. Very young infants can have apnea, poor feeding or difficult breathing without a fever [2].
Does a baby with RSV always need antibiotics?
No. RSV is viral. Antibiotics are used only when a clinician identifies a separate bacterial infection [4].
Is albuterol the standard RSV treatment?
No. The AAP recommends against routine bronchodilators for typical infant bronchiolitis. Oxygen and hydration support are more important when clinically indicated [4].
Are RSV antibodies the same as an RSV vaccine?
No. Nirsevimab and clesrovimab supply ready-made antibodies. Maternal vaccination trains the pregnant patient’s immune system to produce antibodies that pass to the fetus [3].
Should every baby receive maternal vaccination plus an antibody injection?
Usually not. CDC recommends one of these approaches for most infants, guided by timing, maternal vaccination history and the baby’s eligibility [3].
Key takeaways
Watch breathing, feeding and alertness—especially in young infants who may have no fever. Most RSV is managed with supportive care; bronchodilators, steroids and antibiotics are not routine treatment for bronchiolitis. Maternal vaccination or infant long-acting antibodies can help prevent severe disease.
References
- Centers for Disease Control and Prevention. Symptoms and care of RSV. Atlanta: CDC; 20 Feb 2026.
- Centers for Disease Control and Prevention. RSV in infants and young children. Atlanta: CDC; accessed 8 Nov 2026.
- Centers for Disease Control and Prevention. RSV immunization guidance for infants and young children. Atlanta: CDC; updated 18 Aug 2025.
- Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474–e1502. doi:10.1542/peds.2014-2742.
Medical disclaimer: This article provides education, not personalized pediatric care. Babies with breathing problems, apnea, dehydration or reduced responsiveness need immediate clinical assessment. RSV immunization recommendations, products and seasonality vary by country and may change.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.